Statement of Deviation & Variation
Statement Of Deviation & Variation
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Transgene Biotek Limited on 6ix
Earlier from Transgene Biotek
- Compliance-57 (5): intimation after the end of quarter
- Transgene Biotek Limited. Press Release Jul 13 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Transgene Biotek Limited. Press Release Jun 20 2026
- Closure of Trading Window
Later from Transgene Biotek
- Compliance-57 (4): Prior intimation to the beginning of the quarter
- Transgene Biotek Limited. Press Release Jul 22 2026
- Transgene Biotek Limited. Press Release Jul 23 2026
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 07, 2026.
- 1)The Board Considered And Approved The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2026.2) The Board Considered And Approved The Limited Review Report (Standalone & Consolidated) Of The Comp
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek